Related Experiment Video
Updated: May 20, 2026
15:13
High-resolution Spatiotemporal Analysis of Receptor Dynamics by Single-molecule Fluorescence Microscopy
Published on: July 25, 2014
Where have all the active receptor states gone?
H Ongun Onaran1, Tommaso Costa
1Department of Pharmacology, Faculty of Medicine, University of Ankara, Ankara, Turkey. ongun.onaran@medicine.ankara.edu.tr
Nature Chemical Biology
|July 20, 2012
Summary
Precise chemical definitions for G protein-coupled receptor ligand efficacy and biased agonism remain challenging. Applying enzyme-based concepts may offer a path forward for understanding these complex receptor interactions.
Area of Science:
- Pharmacology and Structural Biology
- Biochemistry of Receptor Signaling
Background:
- G protein-coupled receptors (GPCRs) are crucial drug targets.
- Current structural data for GPCRs presents challenges in defining ligand efficacy and biased agonism precisely.
- Existing conceptual frameworks for enzymes may be applicable to GPCRs.
Purpose of the Study:
- To explore the challenges in defining GPCR ligand efficacy and biased agonism using current structural data.
- To investigate the potential application of enzyme-based concepts for understanding GPCR function.
Main Methods:
- Analysis of existing structural data for G protein-coupled receptors.
- Conceptual comparison between enzyme mechanisms and GPCR ligand interactions.
Main Results:
- Current structural data complicates precise chemical definitions of GPCR ligand efficacy and biased agonism.
- Classical concepts from enzyme kinetics and function may provide a useful framework.
Conclusions:
- Bridging the gap between structural data and functional definitions for GPCRs requires novel conceptual approaches.
- Adapting enzyme-centric principles could advance the understanding of GPCR ligand interactions and signaling bias.
Related Concept Videos
01:29The Two-State Receptor Model
The two-state receptor model explains a drug's interaction with receptors, such as G protein-coupled receptors and ligand-gated ion channels, to induce or inhibit a biological response. When no natural ligands are present, a receptor exists in an equilibrium of inactive (Ri) and active (Ra) conformations. The inactive form does not produce a response, while the active form generates a basal effect known as constitutive activity.
The binding affinity of a drug determines its interaction with one...
The binding affinity of a drug determines its interaction with one...
01:30Spare Receptors
Some receptors remain unoccupied even when an agonist produces a maximal response. Such empty ones are called spare receptors. In presence of spare receptors the maximum effect of an agonist drug is achieved with fewer than 100% of the receptors being occupied. To determine the presence of spare receptors, scientists often compare the concentration of the drug needed to produce 50% of the maximum effect (EC50) with the concentration of the drug needed to occupy 50% of the receptors (Kd). If the...
01:15Receptor Downregulation in MVBs
Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
The EGFR can initiate signaling pathways that lead to cell proliferation, migration, and differentiation. Overexpression of EGFR stimulates cells to proliferate. Excessive EGFR activation may...
01:12GPCR Desensitization
G protein-coupled receptor (GPCR) signaling plays a crucial role in cell functioning. GPCR desensitization is an equally essential process. It allows cells to respond to changing environments and regain sensitivity to new stimuli while preventing unnecessary stimulation when no longer needed. Prolonged exposure to stimuli leads to GPCR desensitization. It involves blocking the receptors from binding and activating additional G proteins. This inhibits activation of downstream effectors, thereby...
01:22Activation and Inactivation of G Proteins
Heterotrimeric G proteins are guanine nucleotide-binding proteins. As the name suggests, heterotrimeric G proteins are composed of three subunits: alpha, beta, and gamma. They remain GDP-bound or GTP-bound inside the cells and switch between inactive/active states. The Gα subunit possesses the nucleotide-binding pocket that binds guanine nucleotides and switches between GDP or GTP-bound states. In contrast, the Gꞵ and Gγ subunits are always bound together with high affinity and are together...
01:25Drug-Receptor Interaction: Agonist
Agonists are drugs that interact with specific receptors in the body to produce a biological response. When an agonist binds to a receptor, it activates or enhances the receptor's function, leading to physiological effects. The interaction between agonist drugs and receptors is crucial for their therapeutic action in various medical treatments.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.
Agonists can bind to receptors in different ways. Some agonists bind directly to the receptor's active site, mimicking the endogenous ligand's action.